CAVHANZA
Nilotinib
- Strength
- 80 mg/1
- Form
- Tablet, Orally Disintegrating
- Class
- Kinase Inhibitor
Cycle Pharmaceuticals Ltd
Not stocked by us — reference only
Nilotinib
Listed by Cycle Pharmaceuticals Ltd
| Dosage form | Tablet, Orally Disintegrating |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 70709-191 |
| FDA application | NDA217379 |
| RxNorm concept | 2747509 |
| Package sizes listed | 1 |
| Marketed since | June 2026 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Nilotinib
Cycle Pharmaceuticals Ltd
Not stocked by us — reference only
nilotinib
Azurity Pharmaceuticals, Inc.
Not stocked by us — reference only
nilotinib
Azurity Pharmaceuticals, Inc.
Not stocked by us — reference only
Novadoz Pharmaceuticals LLC
Not stocked by us — reference only
Cipla USA Inc.
Not stocked by us — reference only
Novadoz Pharmaceuticals LLC
Not stocked by us — reference only
EXELAN PHARMACEUTICALS INC.
Not stocked by us — reference only
Camber Pharmaceuticals, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.